Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.43 |
| ▸ | ANPEP | P15144 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | ALPI | P09923 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | XIAP | P98170 | 1/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9871271 | 0.95 | EPHX1 (0.50) | EPHX1TAAR1SIGMAR1SLC6A2MAOA | |
| SCHEMBL10664680 | 0.86 | EPHX1 (0.43) | EPHX1TAAR1SIGMAR1SLC6A2MAOA | |
| SCHEMBL21121205 | 0.86 | TRPA1 (0.47) | EPHX1TAAR1SIGMAR1SLC6A2MAOA | |
| SCHEMBL4981467 | 0.83 | EPHX1 (0.60) | EPHX1TAAR1SIGMAR1SLC6A2MAOA | |
| SCHEMBL4587541 | 0.81 | SIGMAR1 (0.43) | SIGMAR1MAOA | |
| Ammonia Solution, Strong SCHEMBL21412646 | 0.80 | EPHX1 (0.57) | EPHX1TAAR1SIGMAR1SLC6A2MAOA | |
| SCHEMBL5151522 | 0.80 | EPHX1 (0.46) | EPHX1TAAR1SIGMAR1SLC6A2MAOA | |
| SCHEMBL3544754 | 0.80 | SIGMAR1 (0.45) | SIGMAR1MAOA | |
| SCHEMBL6835652 | 0.79 | EPHX1 (0.50) | EPHX1TAAR1SIGMAR1SLC6A2MAOA | |
| SCHEMBL523308 | 0.77 | EPHX1 (0.48) | EPHX1TAAR1SIGMAR1SLC6A2MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4328659-A1 | SOFT OPHTHALMIC LENS AND METHOD FOR MANUFACTURING SAME | National Institute for Materials Science (JP) | 2024-02-28 | — | — | EP | disclosed |
| CN-117203571-A | Soft spectacle lens and method for manufacturing same | 国立研究开发法人物质·材料研究机构 | 2023-12-08 | — | — | CN | disclosed |
| CN-113149858-B | Synthesis method of intermolecular N-N bonding and compound correspondingly synthesized | 南开大学 | 2023-01-17 | — | — | CN | disclosed |
| CN-113149858-A | Synthesis method of intermolecular N-N bonding and compound correspondingly synthesized | 南开大学 | 2021-07-23 | — | — | CN | disclosed |
| US-20060264480-A1 | Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same | SUH YOUNG G | 2006-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264480-A1 | Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same | TRPV1, TRPA1, TRPV5 | EPHX1 2935/4885TAAR1 409/4885SIGMAR1 504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.